BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9280283)

  • 1. Missense mutations affecting a conserved cysteine pair in the TH domain of Btk.
    Vihinen M; Nore BF; Mattsson PT; Bäckesjö CM; Nars M; Koutaniemi S; Watanabe C; Lester T; Jones A; Ochs HD; Smith CI
    FEBS Lett; 1997 Aug; 413(2):205-10. PubMed ID: 9280283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
    J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
    Saha BK; Curtis SK; Vogler LB; Vihinen M
    Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.
    Hyvönen M; Saraste M
    EMBO J; 1997 Jun; 16(12):3396-404. PubMed ID: 9218782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo.
    Yang W; Malek SN; Desiderio S
    J Biol Chem; 1995 Sep; 270(35):20832-40. PubMed ID: 7657668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.
    Patel HV; Tzeng SR; Liao CY; Chen SH; Cheng JW
    Proteins; 1997 Dec; 29(4):545-52. PubMed ID: 9408950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
    Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
    J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
    Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
    Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
    Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
    J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
    Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
    Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
    Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
    Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BTK, the tyrosine kinase affected in X-linked agammaglobulinemia.
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 1997 Jan; 2():d27-42. PubMed ID: 9159207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate.
    Baraldi E; Djinovic Carugo K; Hyvönen M; Surdo PL; Riley AM; Potter BV; O'Brien R; Ladbury JE; Saraste M
    Structure; 1999 Apr; 7(4):449-60. PubMed ID: 10196129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
    Mattsson PT; Vihinen M; Smith CI
    Bioessays; 1996 Oct; 18(10):825-34. PubMed ID: 8885720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
    Vihinen M; Belohradsky BH; Haire RN; Holinski-Feder E; Kwan SP; Lappalainen I; Lehväslaiho H; Lester T; Meindl A; Ochs HD; Ollila J; Vorechovsky I; Weiss M; Smith CI
    Nucleic Acids Res; 1997 Jan; 25(1):166-71. PubMed ID: 9016530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
    Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
    Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype.
    Gaspar HB; Ferrando M; Caragol I; Hernandez M; Bertran JM; De Gracia X; Lester T; Kinnon C; Ashton E; Espanol T
    Clin Exp Immunol; 2000 May; 120(2):346-50. PubMed ID: 10792386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.
    Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW
    Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.